Skip to main content

Assessing the Role of Paralog-Specific Sumoylation of HDAC1

  • Protocol
  • First Online:
HDAC/HAT Function Assessment and Inhibitor Development

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1510))

Abstract

Attachment of ubiquitin or ubiquitin-like (Ubl) modifiers, such as the small ubiquitin-related modifier SUMO, is a posttranslational modification (PTM) that reversibly regulates the function and the stability of target proteins. The SUMO paralogs SUMO1 and SUMO2/3, although sharing a common conjugation pathway, seem to play different roles in the cell. Many regulatory mechanisms, which contribute to SUMO-paralog-specific modification, have emerged. We have recently found that cell environment affects SUMO-paralog-specific sumoylation of HDAC1, whose conjugation to SUMO1 and not to SUMO2 facilitates its protein turnover. Here, we describe how to identify SUMO-paralog-specific conjugation of HDAC1 and how the different expression of SUMO E3 ligases in the cell plays an important role in this mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Spiegel S, Milstien S, Grant S (2012) Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. Oncogene 31:537–551

    CAS  PubMed  Google Scholar 

  2. Minamiya Y, Ono T, Saito H et al (2011) Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung. Lung Cancer 74:300–304

    Article  PubMed  Google Scholar 

  3. Citro S, Miccolo C, Meloni L et al (2015) PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression. J Mol Cell Biol 7:132–142

    Article  PubMed  Google Scholar 

  4. Colombo R, Boggio R, Seiser C et al (2002) The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1. EMBO Rep 3:1062–1068

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Li Y, Li X, Guo B (2010) Chemopreventive agent 3,3′-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases. Cancer Res 70:646–654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Geiss-Friedlander R, Melchior F (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8:947–956

    Article  CAS  PubMed  Google Scholar 

  7. Geoffroy MC, Hay RT (2009) An additional role for SUMO in ubiquitin-mediated proteolysis. Nat Rev Mol Cell Biol 10:564–568

    Article  CAS  PubMed  Google Scholar 

  8. Passmore LA, Barford D (2004) Getting into position: the catalytic mechanisms of protein ubiquitylation. Biochem J 379:513–525

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rosas-Acosta G, Russell WK, Deyrieux A et al (2005) A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics 4:56–72

    Article  CAS  PubMed  Google Scholar 

  10. Vertegaal AC, Andersen JS, Ogg SC et al (2006) Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics 5:2298–2310

    Article  CAS  PubMed  Google Scholar 

  11. David G, Neptune MA, DePinho RA (2002) SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem 277:23658–23663

    Article  CAS  PubMed  Google Scholar 

  12. Citro S, Jaffray E, Hay RT et al (2013) A role for paralog-specific sumoylation in histone deacetylase 1 stability. J Mol Cell Biol 5:416–427

    Article  CAS  PubMed  Google Scholar 

  13. Flotho A, Melchior F (2013) Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem 82:357–385

    Article  CAS  PubMed  Google Scholar 

  14. Desterro JM, Rodriguez MS, Hay RT (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2:233–239

    Article  CAS  PubMed  Google Scholar 

  15. Tatham MH, Jaffray E, Vaughan OA et al (2001) Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 276:35368–35374

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro to Susanna Chiocca (AIRC IG5732, AIRC IG12075). SCi was supported by a fellowship from Fondazione Umberto Veronesi (FUV).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanna Chiocca .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this protocol

Cite this protocol

Citro, S., Chiocca, S. (2017). Assessing the Role of Paralog-Specific Sumoylation of HDAC1. In: Krämer, O. (eds) HDAC/HAT Function Assessment and Inhibitor Development. Methods in Molecular Biology, vol 1510. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6527-4_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6527-4_24

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6525-0

  • Online ISBN: 978-1-4939-6527-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics